Tolerogenic DCs loaded with apoptotic bodies from the NIT-1 beta-cell line were effectively used in diabetes prevention in the RIP-IFN-β transgenic NOD mice (13); however, by this approach tolDCs are not exposed to a single antigenic entity. The gene discussed is IFNB1; the disease is diabetes mellitus.